On May 29, 2026, Boston Children’s Hospital described a program that integrates artificial intelligence across clinical, research and administrative work to improve care for pediatric patients, particularly those with complex or rare conditions.
Enterprise AI layer and governance
Initial one-off AI tools for documentation and translation were replaced by what the hospital calls an enterprise AI layer: a secure internal ChatGPT environment available to research, clinical and administrative teams. John Brownstein, Chief Innovation Officer, said governance structures were implemented alongside the technology to ensure safety, monitoring and consistent evaluation.
The hospital reported that the shared environment lets teams develop and deploy new capabilities more quickly than earlier, siloed projects and that more than one-third of employees now use AI in daily work.
Operational redesign and measurable savings
Boston Children’s applied AI to supply chain, billing, scheduling and other repetitive tasks. The organization says AI now handles invoice intake and routing and supports surgical scheduling by analyzing clinical notes and estimating patient acuity, enabling longer-range planning of operating room time.
Across more than 50 automations, the hospital reports roughly 60,000 hours saved, which it equates to over $7 million in redeployed labor. The hospital framed these changes as efforts to make AI relevant to everyday work rather than as standalone experiments.
Rare disease diagnosis and research
The hospital developed a so-called “co-pilot geneticist” to combine genetic and phenotypic data with literature synthesis. Boston Children’s reports that this system has produced more than 40 diagnoses that had previously gone unresolved and has contributed to the identification of new gene targets and potential therapeutic pathways.
Brownstein described the approach as combining genetic information, phenotypic information, literature search and AI reasoning to deliver diagnoses for families who lacked answers. The hospital says it is working to embed AI more fully into clinical decision-making, extend tools across specialties and continue refining models through collaboration with OpenAI.
Original source: OpenAI News